Hospital Universitario de Valladolid -ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

  2. Impact of intra-abdominal pressure on early kidney transplant outcomes

    Scientific reports, Vol. 12, Núm. 1, pp. 2257

2020

  1. Validation of a survival benefit estimator tool in a cohort of European kidney transplant recipients

    Scientific Reports, Vol. 10, Núm. 1

2017

  1. Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function

    PLoS ONE, Vol. 12, Núm. 2

  2. Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review

    Medicina Clinica, Vol. 149, Núm. 12, pp. 523-535

  3. ¿Son los recuentos de células T reguladoras en sangre periférica un biomarcador predictivo y pronóstico para mejorar los resultados en el trasplante renal?: una revisión sistemática

    Diálisis y trasplante: publicación oficial de la Sociedad Española de Diálisis y Trasplante, Vol. 38, Núm. 1, pp. 40-56

2016

  1. Reversible posterior leukoencephalopathy syndrome: A recurrent and atypical case in hemodialysis

    Nefrologia

  2. Reversible posterior leukoencephalopathy syndrome: A recurrent and atypical case in hemodialysis

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 2, pp. 192-193

2015

  1. Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: An insight into current clinical practice

    Transplant International, Vol. 28, Núm. 9, pp. 1042-1054

2010

  1. Heterogeneity of induction therapy in Spain: Changing patterns according to year, centre, indications and results

    NDT Plus, Vol. 3, Núm. SUPPLL. 2

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2005

  1. Cystatin C as a marker of renal function in kidney transplant patients

    Transplantation Proceedings

2004

  1. Recipient age as a determinant factor of patient and graft survival

    Nephrology Dialysis Transplantation, Vol. 19, Núm. SUPPL. 3

2003

  1. Tacrolimus-basiliximab versus cyclosporine-basiliximab in renal transplantation "de novo": Acute rejection and complications

    Transplantation Proceedings

2000

  1. The use of antihypertensive therapy in Spain (1986-1994)

    American Journal of Hypertension, Vol. 13, Núm. 6 II SUPPL., pp. 607-610

1995

  1. Nefrotoxicidad por aciclovir

    Anales de Medicina Interna, Vol. 12, Núm. 10, pp. 501-502